Amgen investment arm Amgen Ventures participated in a $30 million funding round for San Francisco precision oncology startup Syapse. The Thousand Oaks-based biotech giant joined several other investors, including Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Roche Venture Fund, Merck Global Health and others, Syapse announced Nov. 14. The Series D financing round will…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
